Consistent with the in vitro results, MC38‐tumor‐infiltrating cDC1 also showed upregulated CD40, CD80, CD86, and MHC‐II expression after RA treatment (Figure 3I–L; Figure S4E–H, Supporting Information). This evidence concerns the gene CD86 and neoplasm.